RARA CRAFT DATABASE for FDA Medical Devices
510(k)K202101

FDA DEVICE FACTS

GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Test (ACT-LR), directCHECK ACT+ Whole Blood Control, Level 1 and Level 2, directCHECK ACT-LR Whole Blood Control, Level 1 and Level 2

Accriva Diagnostics, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEDecember 29, 2021PRODUCT CODEJPA

Indications for use

GEM Hemochron 100 System: The GEMB HemochronTM 100 System is a battery-operated portable instrument that performs individual in vitro quantitative coagulation tests on fresh whole blood. The system is intended to be used with test cartridges available from the manufacturer and include tests for Activated Clotting Time (ACT+) and Low Range Activated Clotting Time (ACT LR). The system is intended for use only in point-of-care settings for patients aged 18 years and above The GEM HemochronTM100 ACT+ (Activated Clotting Time Plus) test is a quantitative assay for monitoring anticoagulation with moderate to high unfractionated heparin (UFH) doses in fresh whole blood samples. This test is intended for monitoring UFH administered during cardiovascular surgery and cardiac ablation procedures. The GEM® HemochronTM 100 ACT+ demonstrates linear correlation to the anticoagulation effects of UFH concentrations of 1.0 to 6.0 units/mL The GEM® HemochronTM 100 ACT-LR (Low Range Activated Clotting Time) test is a quantitative assay for monitoring anticoagulation with low to moderate unfractionated heparin (UFH) doses in fresh whole blood samples This test is intended for monitoring UFH administered during extracorporeal life support and cardiology procedures. The GEM® HemochronTM 100 ACT-LR test demonstrates linear correlation to the anticoagulation effects of UFH concentrations up to 2.5 units/mL For in vitro diagnostic use. For Professional Use, Rx Only. GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+);: The GEM® HemochronTM 100 ACT+ (Activated Clotting Time Plus) test is a quantitative assay for monitoring anticoagulation with moderate to high unfractionated heparin (UFH) doses in fresh whole blood samples. This test is intended for monitoring UFH administered during cardiovascular surgery and cardiac ablation procedures. The GEM® HemochronTM 100 ACT+ demonstrates linear correlation to the anticoagulation effects of UFH concentrations of 1.0 to 6.0 units/mL The GEMB HemochronTM 100 ACT+ test can be performed on the GEM® HemochronTM 100 System and any model of HemochronTM Signature Series device. Each instrument is portable, which allows testing at the pont-of-care. For in vitro diagnostic use. For Professional Use, Rx Only GEM Hemochron 100 Low Range Activated Clotting Time Test (ACT-LR): The GEM® HemochronTM 100 ACT-LR (Low Range Activated Clotting Time) test is a quantitative assay for monitoring anticoagulation with low to moderate unfractionated heparin (UFH) doses in fresh whole blood samples. This test is intended for monitoring UFH administered during extracorporeal life support and cardiology procedures The GEM® HemochronTM 100 ACT-LR test demonstrates linear correlation to the anticoagulation etfects of UFH concentrations up to 2.5 units/mL. The GEM Hemochron 100 ACT-LR test can be performed on the GEM® HemochronTM 100 sy stem and any model of HemochronTM Signature Series device. Instruments are portable, which allows testing at the point-of-care. For in vitro diagnostic use For Professional Use, Rx Only directCHECK Whole Blood Controls: The directCHECKTM Whole Blood Quality Controls are dried whole blood preparations which have been assayed and are intended to be used to perfom quality control assays using the Hemochron'M test cartridges For in vitro Diagnostic Use. For Professional Use, Rx Only

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026